This is about the time for Gilead to fix public relations and start massively cure US HepC patients. There are three companies to compete the market now. Free market competition will drive the price down and GILD has all the ammunition to fight and secure the market share.
ECB + Yellen contribute to today's market sell off. Hillary's tweet + senator's I(ntelligent/diotic) discovery of Sovaldi pricing caused storms to biotech sector. At end of the day, you wonder where is the best place to park those cash on hand?